Cargando…

Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19

Detalles Bibliográficos
Autores principales:	Diaz, Temistocles, Trachtenberg, Barry H., Abraham, Samuel J. K., KosagiSharaf, Rao, Durant-Archibold, Armando A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734129/ https://www.ncbi.nlm.nih.gov/pubmed/33330639 http://dx.doi.org/10.3389/fcvm.2020.562708

Ejemplares similares

Coagulopathy associated with COVID-19 – Perspectives & Preventive strategies using a biological response modifier Glucan
por: Ikewaki, Nobunao, et al.
Publicado: (2020)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
por: Chen, Yinong, et al.
Publicado: (2021)

Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin
por: Buurma, Marleen, et al.
Publicado: (2019)

Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study
por: Lee, Meng, et al.
Publicado: (2014)

Aspirin for the prevention of preeclampsia: A systematic review and meta-analysis of randomized controlled studies
por: Wang, Yixiao, et al.
Publicado: (2022)

Low-dose aspirin in the prevention of preeclampsia in twin pregnancies: A real-world study
por: Zhou, Qiongjie, et al.
Publicado: (2023)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Khan, Hamzah, et al.
Publicado: (2022)

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
por: Rawal, Shalin, et al.
Publicado: (2022)

Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis
por: Liu, Di, et al.
Publicado: (2023)

Development of anthracycline-induced dilated cardiomyopathy due to mutation on LMNA gene in a breast cancer patient: a case report
por: Kuruc, Jock Chichaco, et al.
Publicado: (2019)

Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis
por: Zheng, Li, et al.
Publicado: (2022)

Antimicrobial Secretions of Toads (Anura, Bufonidae): Bioactive Extracts and Isolated Compounds against Human Pathogens
por: Rodriguez, Candelario, et al.
Publicado: (2020)

Double-blind, placebo-controlled randomised clinical trial to evaluate the effect of ASPIRIN discontinuation after left atrial appendage occlusion in atrial fibrillation: protocol of the ASPIRIN LAAO trial
por: Chen, Mu, et al.
Publicado: (2021)

Editorial: Physical activity and exercise for the prevention and management of cardiovascular risk and cardiovascular disease
por: Volterrani, Maurizio, et al.
Publicado: (2023)

Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study
por: Petersohn, Svenja, et al.
Publicado: (2020)

Editorial: Insights in cardiovascular epidemiology and prevention: 2022
por: Lin, Gen-Min
Publicado: (2023)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

Effect of aspirin in takotsubo syndrome: protocol of a systematic review and meta-analysis
por: Lin, Jinhai, et al.
Publicado: (2021)

General practitioners’ use of absolute risk versus individual risk factors in cardiovascular disease prevention: an experimental study
por: Jansen, Jesse, et al.
Publicado: (2014)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Mechanisms of Cardiovascular System Injury Induced by COVID-19 in Elderly Patients With Cardiovascular History
por: Yang, Yaliu, et al.
Publicado: (2022)

Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews
por: Collins, Dylan R J, et al.
Publicado: (2017)

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews
por: Byrne, Paula, et al.
Publicado: (2019)

Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC)
por: Volpe, Massimo, et al.
Publicado: (2023)

Renal safety evaluation of aspirin plus edaravone in patients with ischaemic stroke: a retrospective cohort study
por: Yang, Hui-qin, et al.
Publicado: (2022)

Protective Value of Aspirin Loading Dose on Left Ventricular Remodeling After ST-Elevation Myocardial Infarction
por: Calvieri, Camilla, et al.
Publicado: (2022)

Platelet Aggregation Before Aspirin Initiation in Pediatric Patients With Congenital Heart Disease at High Risk of Thrombosis
por: Lu, Zhong-Yuan, et al.
Publicado: (2022)

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
por: van Gils, Paul F, et al.
Publicado: (2011)

Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease
por: Wood, Frances, et al.
Publicado: (2015)

Cardiovascular Prevention: Migrating From a Binary to a Ternary Classification
por: Doneen, Amy Lynn, et al.
Publicado: (2020)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2021)

Editorial: Advances in the Prevention and Rehabilitation of Cardiovascular Diseases via Aerobic Exercise
por: Cao, Richard Y., et al.
Publicado: (2022)

Editorial: Renal function and related biomarkers in cardiovascular risk assessment and prevention
por: Lin, Gen-Min, et al.
Publicado: (2022)

Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
por: Studzin´ski, Krzysztof, et al.
Publicado: (2017)

Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence
por: Dimitriadis, Kyriakos, et al.
Publicado: (2022)

Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality?
por: Bartoloni, Elena, et al.
Publicado: (2018)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Kandil, Omneya A., et al.
Publicado: (2022)

Health literacy and cardiovascular disease prevention: a systematic scoping review protocol
por: Beasant, Bonnie, et al.
Publicado: (2022)

Vascular biomarkers in the prevention of childhood cardiovascular risk: From concept to clinical implementation
por: Hanssen, Henner
Publicado: (2022)

High sensitivity troponins: A potential biomarkers of cardiovascular risk for primary prevention
por: Leite, Luis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e7ufnjohfv0fvoeqjtl4a017gs